It’s a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.
Source: US Top News and Analysis
Related Posts
Goldman is betting Nvidia will get a boost from health care as industry builds out AI capabilities
Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost…
UK eases rules for hedge funds in sweeping overhaul of short selling rules
The U.K.’s Financial Conduct Authority has overhauled its rules on short-selling. Source: US Top News…
Oil prices surge with Brent rising 5% as Trump vows to hit Iran ‘extremely hard’ within weeks
Oil rose in volatile trading as Trump in his address to the nation on Iran…